Share the Video:

Studying ketamine-assisted therapy Q&A

Franklin King, Benjamin Lewis, Eric Garland, Henry Macconel, Juliana Zambrano, Nicole Galvão-Coelho, Sharon Niv

Ketamine-assisted psychotherapy (KAP) is rapidly gaining recognition for its diverse applications in mental healthcare. This session will offer a comprehensive overview of the latest studies and insights in KAT, exploring its efficacy across a spectrum of conditions. Discussions will include the integration of KAT with mindfulness-oriented recovery enhancement for substance use disorders, its implementation and accessibility within public health systems, and the nuanced relationship between ketamine’s psychoactive effects and therapeutic outcomes. Additionally, the panel will delve into real-world effectiveness of KAT for complex conditions like PTSD and depression. Attendees will gain a deeper understanding of current research trends, practical applications, and the evolving landscape of ketamine in clinical practice.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Related Videos